Your browser doesn't support javascript.
loading
Disitamab Vedotin (RC48) for HER2-positive advanced breast cancer: a case report and literature review.
Li, Yang; Zhang, Jingjiao; Cai, Zhengang; Gao, Xue; Zhang, Lina; Lu, Zhi; Wang, Xiaojie; Yu, Peiyao; Li, Jia; Fang, Fengqi.
Afiliación
  • Li Y; Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Zhang J; Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Cai Z; Department of Breast Surgery, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Gao X; Department of Pathology, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Zhang L; Imaging and Nuclear Medicine Department, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Lu Z; Nuclear Medicine Department, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Wang X; Department of Radiotherapy, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Yu P; Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Li J; Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
  • Fang F; Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, China.
Front Oncol ; 13: 1286392, 2023.
Article en En | MEDLINE | ID: mdl-38074635

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza